Information and Resources |
INOMAX® is a vasodilator, which, in conjunction with ventilatory support and other appropriate agents, is indicated for the treatment of term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension, where it improves oxygenation and reduces the need for extracorporeal membrane oxygenation.
INOMAX Important Safety Information (ISI)
INOMAX should not be used in the treatment of neonates known to be dependent on right-to-left shunting of blood
Information and Resources
The following resource pages are provided to help clinicians make informed decisions about the use of INOMAX in the treatment of their term and near-term neonatal patients with Hypoxic Respiratory Failure.
Click on the area of interest for which you would like information.
- References
- Study Descriptions
-
Important Safety Information
- INOMAX Hospital Users
- International Contacts
- Clinical Data
- Full Prescribing Information